Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › raloxifene

raloxifene

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of raloxifene

9 trials tracked of raloxifene: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 30 citations.

9Trials tracked
6Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 3 Phase 3 3 Phase 2 1 Other / NA 2
  1. Phase 4 Raloxifene and Rimostil for Perimenopause-Related Depression Completed · 30 cited
  2. Phase 3 Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients. Completed · 29 cited
  3. Phase 3 Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome Completed · 17 cited
  4. Phase 4 Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window? Completed
  5. Phase 4 Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density Completed
  6. Phase 3 Cognition in the Study of Tamoxifen and Raloxifene Completed
Show 3 more trials
  1. Phase 2 Raloxifene for Women With Alzheimer's Disease Completed
  2. N/A Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) Completed
  3. N/A Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Raloxifene SNP Study: Investigating ER and UGT Gene Impact on Breast Cancer Outcomes
OB/GYN & Women's Health Phase III
Raloxifene SNP Study: Investigating ER and UGT Gene Impact on Breast Cancer Outcomes Can a Common Breast Cancer Drug Work Better for Some Patients?
This Phase 2/3 trial examines the relationship between ER and UGT SNPs and Raloxifene's efficacy and side effects in 600 BC-LCIS patients. R…
A study is testing if genetic markers can predict which breast cancer patients respond best to Raloxifene, potentially tailoring treatment f…
CT.gov Mar 27, 2026